A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder

Authors

Institutions

Publication Details

Journal
Journal of Oral & Facial Pain and Headache
Published
2025-01-01
DOI
https://doi.org/10.22514/jofph.2025.027
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder

Ana G. Gossweiler, George J. Eckert, Domenick T. Zero, Kurt Kroenke et al.
Journal of Oral & Facial Pain and Headache
HER2/EGFR in Cancer Research
article

A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder

Ana G. Gossweiler, George J. Eckert, Domenick T. Zero, Kurt Kroenke, Harold C. Ávila, Lorena Del Carmen Galvez
article en

Abstract

No abstract available for this paper.
Journal of Oral & Facial Pain and HeadacheVol. 39(2)
Indiana University Health (US), Regenstrief Institute (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Openalex Percentile: Top 80%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.